Ca2+ enhances Aβ polymerization rate and fibrillar stability in a dynamic manner

Biochemical Journal

Volumn 450, Issue 1, 2013, Pages 189-197

  Brännström, Kristoffer ^a   Öhman, Anders ^a   Lindhagen Persson, Malin ^a   Olofsson, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyloid; Amyloid peptide (A ); Atomic force microscopy (AFM); Ca2+; NMR; Surface plasmon resonance (SPR)

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM ION; MONOMER;

AMINO TERMINAL SEQUENCE; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL MATURATION; FIBER; NUCLEAR MAGNETIC RESONANCE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CALCIUM; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ATOMIC FORCE; PEPTIDE FRAGMENTS; POLYMERIZATION; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 84873020544     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20121583     Document Type: Article

References (45)

1. Wilson, C. A., Doms, R. W. and Lee, V. M. (2003) Distinct presenilin-dependent and presenilin-independent gamma-secretases are responsible for total cellular Aβ production. J. Neurosci. Res. 74, 361-369
2. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N. and Ihara, Y. (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13, 45-53
3. Jarrett, J. T., Berger, E. P. and Lansbury, Jr, P. T. (1993) The C-terminus of the β protein is critical in amyloidogenesis. Ann. N.Y. Acad. Sci. 695, 144-148
4. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L. and Markesbery, W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52
5. Yumoto, S., Kakimi, S., Ohsaki, A. and Ishikawa, A. (2009) Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease. J. Inorg. Biochem. 103, 1579-1584
6. Ricchelli, F., Drago, D., Filippi, B., Tognon, G. and Zatta, P. (2005) Aluminum-triggered structural modifications and aggregation of β-amyloids. Cell. Mol. Life Sci. 62, 1724-1733
7. Kawahara, M., Kato, M. and Kuroda, Y. (2001) Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res. Bull. 55, 211-217
8. Ha, C., Ryu, J. and Park, C. B. (2007) Metal ions differentially influence the aggregation and deposition of Alzheimer's β-amyloid on a solid template. Biochemistry 46, 6118-6125
9. Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M., Romano, D. M., Hartshorn, M. A., Tanzi, R. E. and Bush, A. I. (1998) Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273, 12817-12826
10. 2+. FEBS J. 276, 4051-4060
11. Stutzmann, G. E. (2005) Calcium dysregulation, IP3 signaling, and Alzheimer's disease. Neuroscientist 11, 110-115
12. Guo, Q., Furukawa, K., Sopher, B. L., Pham, D. G., Xie, J., Robinson, N., Martin, G. M. and Mattson, M. P. (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. NeuroReport 8, 379-383
13. Brzyska, M. and Elbaum, D. (2003) Dysregulation of calcium in Alzheimer's disease. Acta Neurobiol. Exp. 63, 171-183
14. Gallego-Sandin, S., Alonso, M. T. and Garcia-Sancho, J. (2011) Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of the endoplasmic reticulum (ER) and triggers ER stress. Biochem. J. 437, 469-475
15. Isaacs, A. M., Senn, D. B., Yuan, M., Shine, J. P. and Yankner, B. A. (2006) Acceleration of amyloid β-peptide aggregation by physiological concentrations of calcium. J. Biol. Chem. 281, 27916-27923
16. Itkin, A., Dupres, V., Dufrene, Y. F., Bechinger, B., Ruysschaert, J. M. and Raussens, V. (2011) Calcium ions promote formation of amyloid β-peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer's disease. PLoS ONE 6, e18250
17. Myszka, D. G. (1999) Improving biosensor analysis. J. Mol. Recognit. 12, 279-284
18. Williams, A. D., Shivaprasad, S. and Wetzel, R. (2006) Alanine scanning mutagenesis of Aβ1-40 amyloid fibril stability. J. Mol. Biol. 357, 1283-1294
19. Williams, A. D., Portelius, E., Kheterpal, I., Guo, J. T., Cook, K. D., Xu, Y. and Wetzel, R. (2004) Mapping Aβ amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335, 833-842
20. Brannstrom, K., Ohman, A. and Olofsson, A. (2011) Aβ peptide fibrillar architectures controlled by conformational constraints of the monomer. PLoS ONE 6, e25157
21. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J. and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293
22. Johnson, B. A. and Blevins, R. A. (1994) NMR View: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4, 603-614
23. Hou, L. and Zagorski, M. G. (2006) NMR reveals anomalous copper(II) binding to the amyloid Aβ peptide of Alzheimer's disease. J. Am. Chem. Soc. 128, 9260-9261
24. Olofsson, A., Sauer-Eriksson, A. E. and Ohman, A. (2006) The solvent protection of alzheimer amyloid-β-(1-42) fibrils as determined by solution NMR spectroscopy. J. Biol. Chem. 281, 477-483
25. Olofsson, A., Lindhagen-Persson, M., Sauer-Eriksson, A. E. and Ohman, A. (2007) Amide solvent protection analysis demonstrate that Amyloid-β1-40 and Amyloid-β1-42 form different fibrillar structures under identical conditions. Biochem. J. 404, 63-70
26. Ippel, J. H., Olofsson, A., Schleucher, J., Lundgren, E. and Wijmenga, S. S. (2002) Probing solvent accessibility of amyloid fibrils by solution NMR spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 99, 8648-8653
27. Olofsson, A., Sauer-Eriksson, A. E. and Ohman, A. (2009) Amyloid fibril dynamics revealed by combined hydrogen/deuterium exchange and nuclear magnetic resonance. Anal. Biochem. 385, 374-376
28. Esler, W. P., Stimson, E. R., Jennings, J. M., Vinters, H. V., Ghilardi, J. R., Lee, J. P., Mantyh, P. W. and Maggio, J. E. (2000) Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39, 6288-6295
29. Cannon, M. J., Williams, A. D., Wetzel, R. and Myszka, D. G. (2004) Kinetic analysis of beta-amyloid fibril elongation. Anal. Biochem. 328, 67-75
30. Hu, W. P., Chang, G. L., Chen, S. J. and Kuo, Y. M. (2006) Kinetic analysis of β-amyloid peptide aggregation induced by metal ions based on surface plasmon resonance biosensing. J. Neurosci. Methods 154, 190-197
31. Hasegawa, K., Ono, K., Yamada, M. and Naiki, H. (2002) Kinetic modeling and determination of reaction constants of Alzheimer's β-amyloid fibril extension and dissociation using surface plasmon resonance. Biochemistry 41, 13489-13498
32. Corona, C., Pensalfini, A., Frazzini, V. and Sensi, S. L. (2011) New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc. Cell Death Dis. 2, e176
33. Stutzmann, G. E. (2007) The pathogenesis of Alzheimers disease is it a lifelong 'calciumopathy'? Neuroscientist 13, 546-559
34. Itkin, A., Dupres, V., Dufrene, Y. F., Bechinger, B., Ruysschaert, J. M. and Raussens, V. (2011) Calcium ions promote formation of amyloid β-peptide1-40 oligomers causally implicated in neuronal toxicity of Alzheimer's disease. PLoS ONE 6, e18250
35. 2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 58, 871-883
36. Rybalchenko, V., Hwang, S. Y., Rybalchenko, N. and Koulen, P. (2008) The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity. Int. J. Biochem. Cell Biol. 40, 84-97
37. 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126, 981-993
38. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W. et al. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivoby the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870
39. Bostrom, F., Hansson, O., Gerhardsson, L., Lundh, T., Minthon, L., Stomrud, E., Zetterberg, H. and Londos, E. (2009) CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies. Neurobiol. Aging 30, 1265-1271
40. Alexander, S. A., Kerr, M. E., Balzer, J., Horowitz, Kassam, M., A., Kim, Y., Hoffman, L. and Conley, Y. P. (2008) Cerebrospinal fluid apolipoprotein E, calcium and cerebral vasospasm after subarachnoid hemorrhage. Biol. Res. Nurs. 10, 102-112
41. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J. and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539
42. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L. et al. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453
43. Walsh, D. M. and Selkoe, D. J. (2007) Aβ oligomers: a decade of discovery. J. Neurochem. 101, 1172-1184
44. Lindhagen-Persson, M., Brannstrom, K., Vestling, M., Steinitz, M. and Olofsson, A. (2010) Amyloid-β oligomer specificity mediated by the IgM isotype: implications for a specific protective mechanism exerted by endogenous auto-antibodies. PLoS ONE 5, e13928
45. Treusch, S., Hamamichi, S., Goodman, J. L., Matlack, K. E., Chung, C. Y., Baru, V., Shulman, J. M., Parrado, A., Bevis, B. J., Valastyan, J. S. et al. (2011) Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science 334, 1241-1245